Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,167,682
  • Shares Outstanding, K 108,753
  • Annual Sales, $ 298,850 K
  • Annual Income, $ -542,730 K
  • 60-Month Beta 1.27
  • Price/Sales 69.23
  • Price/Cash Flow N/A
  • Price/Book 28.57
Trade TXG with:

Options Overview

Details
  • Implied Volatility 57.59%
  • Historical Volatility 54.41%
  • IV Percentile 63%
  • IV Rank 45.36%
  • IV High 76.51% on 04/15/20
  • IV Low 41.89% on 08/26/20
  • Put/Call Vol Ratio 0.15
  • Today's Volume 374
  • Volume Avg (30-Day) 209
  • Put/Call OI Ratio 1.27
  • Today's Open Interest 5,867
  • Open Int (30-Day) 1,463

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.25
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.35
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.55 +22.01%
on 03/25/21
203.20 -5.40%
on 04/14/21
+32.20 (+20.12%)
since 03/12/21
3-Month
140.56 +36.76%
on 03/08/21
203.20 -5.40%
on 04/14/21
+12.33 (+6.85%)
since 01/14/21
52-Week
64.65 +197.32%
on 04/15/20
203.20 -5.40%
on 04/14/21
+125.47 (+187.97%)
since 04/14/20

Most Recent Stories

More News
10x Genomics to Report First Quarter Financial Results on May 5, 2021

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5th, 2021. The company's management will webcast a corresponding...

TXG : 192.22 (-2.60%)
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit

10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new offering designed to put the power of single cell analysis within...

TXG : 192.22 (-2.60%)
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations

City to Change Street Name to 'Genomics Place'

TXG : 192.22 (-2.60%)
10x Genomics to Present at the 41st Annual Cowen Health Care Conference

10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 41st Annual Cowen Health Care Conference.

TXG : 192.22 (-2.60%)
10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event

10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout...

TXG : 192.22 (-2.60%)
10x Genomics: 4Q Earnings Snapshot

PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Wednesday reported a loss of $415.6 million in its fourth quarter.

TXG : 192.22 (-2.60%)
10x Genomics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021

Q4 2020 revenue growth of 49% over prior year

TXG : 192.22 (-2.60%)
10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2020 after market close on Wednesday, February 17, 2021. The company's...

TXG : 192.22 (-2.60%)
4 Under the Radar Biotech Stocks with Major Upside Potential

Biotechnology companies that specialize in niche segments like genomics, cell-technology and genetic analysis are likely to see major upside in their stocks in the near-term. With increasing numbers of...

TXG : 192.22 (-2.60%)
TWST : 142.03 (+0.87%)
PACB : 32.55 (-2.33%)
CDNA : 74.70 (-0.48%)
10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference

10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming 39 Annual J.P. Morgan Virtual Healthcare Conference.

JPM : 151.21 (-1.87%)
TXG : 192.22 (-2.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 213.04
2nd Resistance Point 208.12
1st Resistance Point 200.17
Last Price 192.22
1st Support Level 187.30
2nd Support Level 182.38
3rd Support Level 174.43

See More

52-Week High 203.20
Last Price 192.22
Fibonacci 61.8% 150.27
Fibonacci 50% 133.93
Fibonacci 38.2% 117.58
52-Week Low 64.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar